India could resume shipping vaccines to COVAX in a few weeks: Report
India could resume deliveries of COVID-19 shots to global
vaccine-sharing platform COVAX
in a few weeks for the first time since April, two health industry sources
said, ending a suspension of supplies that has hurt 8 poor countries.
The World Health Organization (WHO), which
co-leads COVAX, has been urging India to restart supplies for the programme,
especially after it sent about 4 million doses to its neighbours and partners
in October.
Based on an informal approval from India,
COVAX officials have started planning allocations of the Covishield shot for
various countries, said one of the sources, both of whom declining to be identified
pending a final agreement.
Covishield is a licensed version of the
AstraZeneca shot made by the Serum Institute of India (SII), the world's
biggest vaccine maker.
SII has nearly quadrupled its output of
Covishield to up to 240 million doses a month since April, when India stopped
all exports in order to inoculate its own people during a surge of cases. Read
More
Comments
Post a Comment